310 results
Page 13 of 16
6-K
EX-99
zpz1kql80axta
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am
6-K
EX-99
b1p42hv6lsuo 339
5 Aug 13
BioLineRx Announces Publication of Positive
12:00am
6-K
EX-99
t3d0ut3ukbn
29 Jul 13
BioLineRx Announces CE-Mark Registration
12:00am
6-K
EX-99
tknmhda93r94vb5fl
10 Jun 13
Current report (foreign)
12:00am
6-K
EX-99
pi7 kfihkn2c
6 Jun 13
Current report (foreign)
12:00am
6-K
EX-99.1
ny2jc7wd
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
6-K
EX-99
i5wp4 1a8mdg3se
7 May 13
BioLineRx Reports First Quarter 2013 Results
12:00am
6-K
EX-99
a8cq2lt5vcxfqffd
29 Apr 13
Current report (foreign)
12:00am
6-K
EX-99
2fqatykjmt42gslvy 3b
17 Apr 13
Current report (foreign)
12:00am
6-K
EX-99
teqnvs3 7q
10 Apr 13
BioLineRx Receives Regulatory Approval to Commence
12:00am
6-K
EX-99
9med dr52mlvs
20 Mar 13
BioLineRx Announces Results from Interim Analysis of
12:00am
6-K
EX-99
dfmvrt0t3 7zg1laf
13 Mar 13
BioLineRx Receives Approval from French Regulatory
12:00am
6-K
EX-99
47iescki1m
12 Mar 13
BioLineRx Reports Year End 2012 Financial Results
12:00am
6-K
EX-99
zf15v lp60lwkaf
28 Feb 13
Current report (foreign)
12:00am
6-K
EX-99.1
kxbck2s3m9w
13 Feb 13
BioLineRx Announces Closing of $8 Million Offering of American
12:00am
424B5
sammajjgwy6hbw4mjb5
6 Feb 13
Prospectus supplement for primary offering
12:00am
6-K
EX-99
m8tadypujqghxg1uhky
4 Feb 13
Current report (foreign)
12:00am
6-K
EX-99
9zcs6z4 em8dbvx
24 Oct 12
Current report (foreign)
12:00am
6-K
EX-99
ek2h0blgqmx5a3zb
16 Oct 12
Current report (foreign)
12:00am